Notably, the cytotoxicity of conventional CAR-T cells to tumor cells significantly decreased as the antigen density decreased, whereas CD2-CAR-T cells effectively maintained decent sensitivity to low-density antigens (Fig. 6B). Here, CD2 is linked to neoplasm.